Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
RelA/NFkB p65 Antibody (112A1021), Alexa Fluor™ 532, Novus Biologicals™

Mouse Monoclonal Antibody
Supplier: Novus Biologicals NB10056712AF532
Description
RelA/NFkB p65 Monoclonal specifically detects RelA/NFkB p65 in Human, Mouse, Rat samples. It is validated for Western Blot, Flow Cytometry, Immunohistochemistry, Immunohistochemistry-Paraffin, Flow (Intracellular).Specifications
RelA/NFkB p65 | |
Monoclonal | |
Alexa Fluor 532 | |
50 mM sodium borate with 0.05% sodium azide | |
RELA | |
This NfkB p65 antibody was raised against a synthetic peptide corresponding to amino acids 526-539 of human NF-kB (p65) protein. | |
0.1 mL | |
Primary | |
Human, Mouse, Rat | |
IgG1 κ |
Western Blot, Flow Cytometry, Immunohistochemistry, Immunohistochemistry (Paraffin) | |
112A1021 | |
Western Blot, Flow Cytometry, Immunohistochemistry, Immunohistochemistry-Paraffin, Flow (Intracellular) | |
MGC131774, nf kb p65, NFkB p65, NF-kB p65, NFKB3v-rel avian reticuloendotheliosis viral oncogene homolog A (nuclear factor ofkappa light polypeptide gene enhancer in B-cells 3 (p65)), Nuclear factor NF-kappa-B p65 subunit, Nuclear factor of kappa light polypeptide gene enhancer in B-cells 3transcription factor p65, p65, RelA, rela p65, v-rel reticuloendotheliosis viral oncogene homolog A (avian), v-rel reticuloendotheliosis viral oncogene homolog A, nuclear factor of kappalight polypeptide gene enhancer in B-cells 3, p65 | |
Mouse | |
Protein G purified | |
Apoptosis, Cancer, Cell Biology, Immune System Diseases, Immunology, Innate Immunity, Neurodegeneration, Neuroscience, Phospho Specific, Signal Transduction, Transcription Factors and Regulators | |
5970.0 | |
Store at 4°C in the dark. |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction